Chemical & Engineering News: Latest News

Extracellular degrader firm raises $130 million to advance into the clinic

GlycoEra is using biologics to degrade autoimmune disease targets, starting with IgG4

May 27, 2025 - 15:45
 0
Extracellular degrader firm raises $130 million to advance into the clinic
GlycoEra is using biologics to degrade autoimmune disease targets, starting with IgG4
Read More

Tags:

Previous Article

Kirigami‐Inspired Breathable Smart Contact Lens for Wireless Monitoring of Corne...

Next Article

Meet the chemical engineer piloting Boeing’s materials innovation

Related Posts

Editorial: Venture capital still likes cleantech

Editorial: Venture capital still likes cleantech

May 20, 2025  0

Biogen taps start-up for RNAi collaboration

Biogen taps start-up for RNAi collaboration

May 28, 2025  0

FDA job cuts hinder drug safety monitoring

FDA job cuts hinder drug safety monitoring

May 12, 2025  0